JP2008531742A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531742A5
JP2008531742A5 JP2008500087A JP2008500087A JP2008531742A5 JP 2008531742 A5 JP2008531742 A5 JP 2008531742A5 JP 2008500087 A JP2008500087 A JP 2008500087A JP 2008500087 A JP2008500087 A JP 2008500087A JP 2008531742 A5 JP2008531742 A5 JP 2008531742A5
Authority
JP
Japan
Prior art keywords
eudragit
nicotine
dissolved
active substance
preferred method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008500087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531742A (ja
JP5308149B2 (ja
Filing date
Publication date
Priority claimed from DE200510010255 external-priority patent/DE102005010255A1/de
Application filed filed Critical
Publication of JP2008531742A publication Critical patent/JP2008531742A/ja
Publication of JP2008531742A5 publication Critical patent/JP2008531742A5/ja
Application granted granted Critical
Publication of JP5308149B2 publication Critical patent/JP5308149B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008500087A 2005-03-07 2006-02-28 無繊維経皮治療システムおよびその製造方法 Expired - Fee Related JP5308149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005010255.7 2005-03-07
DE200510010255 DE102005010255A1 (de) 2005-03-07 2005-03-07 Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
PCT/EP2006/001840 WO2006094681A1 (de) 2005-03-07 2006-02-28 Faserfreies transdermales therapeutisches system und verfahren zu seiner herstellung

Publications (3)

Publication Number Publication Date
JP2008531742A JP2008531742A (ja) 2008-08-14
JP2008531742A5 true JP2008531742A5 (enExample) 2009-03-05
JP5308149B2 JP5308149B2 (ja) 2013-10-09

Family

ID=36538846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008500087A Expired - Fee Related JP5308149B2 (ja) 2005-03-07 2006-02-28 無繊維経皮治療システムおよびその製造方法

Country Status (17)

Country Link
US (2) US11311495B2 (enExample)
EP (1) EP1855660B2 (enExample)
JP (1) JP5308149B2 (enExample)
KR (1) KR20070110093A (enExample)
CN (1) CN101137355B (enExample)
AT (1) ATE517616T1 (enExample)
AU (1) AU2006222242B2 (enExample)
BR (1) BRPI0608067B1 (enExample)
CA (1) CA2598353C (enExample)
DE (1) DE102005010255A1 (enExample)
ES (1) ES2368940T5 (enExample)
IL (1) IL185686A (enExample)
MX (1) MX2007010900A (enExample)
NZ (1) NZ561219A (enExample)
RU (1) RU2386435C2 (enExample)
WO (1) WO2006094681A1 (enExample)
ZA (1) ZA200706885B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
RU2497679C2 (ru) 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
CN101956005B (zh) * 2010-08-13 2012-07-25 司法部司法鉴定科学技术研究所 一种荧光标记的插入缺失遗传多态性位点复合扩增系统及其应用
EP2457565A1 (de) * 2010-11-29 2012-05-30 Ratiopharm GmbH Transdermales therapeutisches System enthaltend Rotigotin
EP2646009A1 (en) * 2010-12-02 2013-10-09 Ratiopharm GmbH Rotigotine ionic liquid
WO2012158483A2 (en) 2011-05-16 2012-11-22 Avery Dennison Corporation Adhesive containing microparticles
KR102242908B1 (ko) 2013-02-07 2021-04-20 애버리 데니슨 코포레이션 개선된 특성을 지니는 항미생물 접착제
US11213432B2 (en) 2013-03-15 2022-01-04 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
WO2014193190A1 (ko) * 2013-05-30 2014-12-04 에스케이케미칼 (주) 로티고틴과 지방산 및 스티렌 점착제를 함유한 경피치료시스템
EP2946775A1 (de) * 2014-05-20 2015-11-25 LTS LOHMANN Therapie-Systeme AG Lavendelöl enthaltendes transdermales therapeutisches System
WO2015188031A2 (en) * 2014-06-05 2015-12-10 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods
DE102015200705A1 (de) 2015-01-19 2016-07-21 Zf Friedrichshafen Ag Hydropneumatische Federung mit passiv lastabhängiger Dämpfventilverstellung
CN105147642B (zh) * 2015-07-31 2018-02-16 大连理工大学 一种含福莫特罗或其富马酸盐的透皮贴剂
CN105505308A (zh) * 2015-12-19 2016-04-20 仇颖超 一种纯天然热熔压敏胶的制备方法
DE102017104026A1 (de) * 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
DE102019117310A1 (de) 2019-06-27 2020-12-31 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Wirkstoffverabreichungssystemen mittels Tampondruckverfahren
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US500461A (en) 1893-06-27 Clothes-pounder
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
JPS61251619A (ja) * 1985-04-30 1986-11-08 Nitto Electric Ind Co Ltd ニコチン含有テ−プ製剤
US5820876A (en) 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
US6126963A (en) * 1986-08-28 2000-10-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3727232A1 (de) * 1987-08-14 1989-02-23 Lohmann Therapie Syst Lts Verfahren zur herstellung einer darreichungs- und/oder dosierungsform fuer arzneimittelwirkstoffe
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
DE4400769C2 (de) 1994-01-13 1996-07-18 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zur Herstellung einer flächigen Darreichungsform mit einer Arzneimittelwirkstoffe enthaltenden Zubereitung
AU676430B2 (en) 1994-03-07 1997-03-06 Theratech, Inc. Drug-containing adhesive composite transdermal delivery device
DE19826592A1 (de) 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
HUP0104728A3 (en) * 1998-12-18 2006-07-28 Alza Corp Mountain View Transparent transdermal nicotine delivery device
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10018834A1 (de) 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
DE10053375C1 (de) 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
DE10110391A1 (de) * 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
DE10317692A1 (de) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Similar Documents

Publication Publication Date Title
JP2007302683A5 (enExample)
JP2006265268A5 (enExample)
JP2009544651A5 (enExample)
JP2008522001A5 (enExample)
JP2010525073A5 (enExample)
JP2009040724A5 (enExample)
JP2009517473A5 (enExample)
JP2007506790A5 (enExample)
JP2011500711A5 (enExample)
JP2006517944A5 (enExample)
JP2009524697A5 (enExample)
NO332405B1 (no) Forbindelse av 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling, deres anvendelse til fremstilling av farmasoytiske midler for behandling av inflammatorisk sykdom og farmasoytisk preparat omfattende forbindelsen.
TW200503786A (en) Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance
JP2009178558A5 (enExample)
JP2008048602A5 (enExample)
JP2007537301A5 (enExample)
JP2005536602A5 (enExample)
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
JP2007510714A5 (enExample)
JP2007521013A5 (enExample)
JP2006519093A5 (enExample)
JP2006516141A5 (enExample)
JP2008520195A5 (enExample)
JP2008519067A5 (enExample)
JP2009523791A5 (enExample)